niacin has been researched along with Parkinsonian Disorders in 3 studies
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fonseca-Fonseca, LA | 1 |
| da Silva, VDA | 1 |
| Wong-Guerra, M | 1 |
| Ramírez-Sánchez, J | 1 |
| Yaquis, ASP | 1 |
| Ochoa-Rodríguez, E | 1 |
| Verdecia-Reyes, Y | 1 |
| de Araújo, FM | 1 |
| Santana, RC | 1 |
| Outeiro, TF | 1 |
| Costa, SL | 1 |
| Núñez-Figueredo, Y | 1 |
| EHLERS, G | 1 |
| MUSTARD, DM | 1 |
3 other studies available for niacin and Parkinsonian Disorders
| Article | Year |
|---|---|
JM-20 protects against 6-hydroxydopamine-induced neurotoxicity in models of Parkinson's disease: Mitochondrial protection and antioxidant properties.
Topics: Animals; Antioxidants; Benzodiazepines; Brain; Male; Mitochondria; Neuroprotective Agents; Niacin; O | 2021 |
[On the applicability of cosaldon in the treatment of cerebral sclerotic parkinsonism].
Topics: Drug Combinations; Niacin; Nicotinic Acids; Parkinson Disease; Parkinsonian Disorders; Theobromine; | 1959 |
TREATMENT OF PARKINSONISM IN ELDERLY PATIENTS WITH COSALDON.
Topics: Cerebrovascular Circulation; Drug Combinations; Drug Therapy; Geriatrics; Intracranial Arteriosclero | 1964 |